Real-world results: Swiss hospitals saw strong mental health improvements in patients given LSD or psilocybin with psychotherapy under a compassionate use program. Safe in clinics: No serious side ...
Microdosing on cannabis is far more prevalent among U.S. adults than previously known. New research from the University of ...
MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
In 1943, biochemist Albert Hoffman accidentally ingested a chemical that he had synthesized from a fungus and discovered that it created hallucinations. The mind-bending chemical was lysergic acid ...
Researchers at a university in Sweden are using acid and ketamine to better understand the workings of the brain, which would then lead to the development of artificial intelligence. The researchers, ...
In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, psychiatry and biology—and became a central component of the counterculture ...
Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results